Abstract:The development of various chemical methods has enabled scientists to decipher the distribution features and biological functions of RNA modifications in the past decade. In addition to modifying noncoding RNAs such as tRNAs and rRNAs, N6-methyladenosine (m6A) has been proven to be the most abundant internal chemical modification on mRNAs in eukaryotic cells and is also the most widely studied mRNA modification to date. Extensive studies have repeatedly demonstrated the important functions of m6A in various biological conditions, ranging from embryonic organ development to adult organ function and pathogenesis. Unlike DNA methylation which is relatively stable, the reversible m6A modification on mRNA is highly dynamic and easily influenced by various internal or external factors, such as cell type, developmental stage, nutrient supply, circadian rhythm, and environmental stresses.In this Account, we review our previous findings on the site selectivity mechanisms regulating m6A formation, as well as the physiological roles of m6A modification in cerebellum development and long-term memory consolidation. In our initial efforts to profile m6A in various types of mouse and human cells, we surprisingly found that the sequence motifs surrounding m6A sites were often complementary with the seed sequences of miRNAs. By manipulating the abundance of the miRNA biogenesis enzyme Dicer or individual miRNAs or mutating miRNA sequences, we were able to reveal a new role of nucleus localized miRNAs, which is to guide the m6A methyltransferase METTL3 to bind to mRNAs and to promote m6A formation. As a result, we partially answered the question of why only a small proportion of m6A motifs within an mRNA could have m6A modification at a certain time point. We further explored the functions of m6A modification in regulating brain development and brain functions. We found that cerebellum had the most severe defects when Mettl3 was knocked out in developing mouse embryonic brain and revealed that the underlying mechanisms could be attributed to aberrant mRNA splicing and enhanced cell apoptosis under m6A deficit conditions. On the other hand, knocking out Mettl3 in postnatal hippocampus did not cause morphological defects in the mouse brain but impaired the efficacy of long-term memory consolidation. Under learning stimuli, formation of m6A modifications could be detected on transcripts encoding proteins related to dendrite growth, synapse formation, and other memory related functions. Loss of m6A modifications on these transcripts would result in translation deficiency and reduced protein production, particularly in the translation of early response genes, and therefore would compromise the efficacy of long-term memory consolidation. Interestingly, excessive training sessions or increased training intensity could overcome such m6A deficiency related memory defects, which is likely due to the longer turnover cycle and the cumulative abundance of proteins throughout the training process. In addition to revealing the roles of m6A modification in regulating long-term memory formation, our work also demonstrated an effective method for studying memory formation efficacy. As the lack of an appropriate model for studying memory formation efficacy has been a long-lasting problem in the field of neural science, our hippocampus-specific postnatal m6A knockout model could also be utilized to study other questions related to memory formation efficacy.

Arhgef2 regulates neural differentiation in the cerebral cortex through mRNA m6A-methylation of Npdc1 and Cend1

Ythdf2-mediated M(6)a Mrna Clearance Modulates Neural Development in Mice

M6a Regulates Neurogenesis and Neuronal Development by Modulating Histone Methyltransferase Ezh2

m6A regulation of cortical and retinal neurogenesis is mediated by the redundant m6A readers YTHDFs

MacroH2A1.2 deficiency leads to neural stem cell differentiation defects and autism‐like behaviors

Critical Regulation Of A Ndime/Mef2c Axis In Embryonic Stem Cell Neural Differentiation And Autism

A Novel M6a Reader Prrc2a Controls Oligodendroglial Specification and Myelination

RNA m6A methylation participates in regulation of postnatal development of the mouse cerebellum

Arl2 Associates with Cdk5rap2 to Regulate Cortical Development via Microtubule Organization

Mettl3‐mediated m6A modification of Lrp2 facilitates neurogenesis through Ythdc2 and elicits antidepressant‐like effects

Arid1a regulates neural stem/progenitor cell proliferation and differentiation during cortical development

METTL3-Dependent N6-Methyladenosine Modification Programs Human Neural Progenitor Cell Proliferation

The methyl binding domain 3/nucleosome remodelling and deacetylase complex regulates neural cell fate determination and terminal differentiation in the cerebral cortex

Mettl5 mediated 18S rRNA N6-methyladenosine (m6A) modification controls stem cell fate determination and neural function

ASH2L regulates postnatal neurogenesis through Onecut2-mediated inhibition of TGF-β signaling pathway

N6-methyladenosine participates in mouse hippocampus neurodegeneration via PD-1/PD-L1 pathway

METTL3-Mediated N6-Methyladenosine Modification Is Involved in the Dysregulation of NRIP1 Expression in Down Syndrome

Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer's disease

FMRP Modulates Neural Differentiation through m6A-Dependent mRNA Nuclear Export

N6-Methyladenosine mRNA Modification: From Modification Site Selectivity to Neurological Functions

m6A epitranscriptomic modification regulates neural progenitor-to-glial cell transition in the retina